Anika Therapeutics Inc. (ANIK) vs Lifecore Biomedical, Inc. (LFCR)
- Anika Therapeutics Inc. ANIK 19.98 −3.43%
- Lifecore Biomedical, Inc. LFCR 6.38 −0.93%
Anika Therapeutics Inc. and Lifecore Biomedical, Inc. are both Drug Manufacturers Specialty & Generic companies. Anika Therapeutics Inc. is the larger, with a market value of $276.9M against $244.1M — 1.1× the size. Anika Therapeutics Inc. grew revenue faster over the last twelve months: 5.33% against −10.0%. Anika Therapeutics Inc. has the higher net margin (−3.14% vs −37.5%) and the lower return on invested capital (−3.24% vs −2.80%). Across the 17 metrics below, Anika Therapeutics Inc. leads on 13 and Lifecore Biomedical, Inc. on 4.
Valuation
Profitability
| Metric | ANIK | LFCR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 62.16% | 26.86% | 53.94% |
| Operating margin | (4.24%) | (6.89%) | 0.00% |
| Net margin | (3.14%) | (37.54%) | 0.00% |
| Free cash flow margin | 0.47% | (4.24%) | 0.00% |
| Return on equity | (2.66%) | 201.15% | (0.40%) |
| Return on assets | (2.04%) | (19.32%) | (3.32%) |
| Return on invested capital | (3.24%) | (2.80%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack